These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 9021182)

  • 1. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
    Zhanel GG; Palatnick L; Nichol KA; Low DE; Hoban DJ;
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1875-81. PubMed ID: 12760861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
    Delmée M; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
    Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study.
    Jacobs MR; Bajaksouzian S; Zilles A; Lin G; Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1901-8. PubMed ID: 10428910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
    Doern GV; Brueggemann A; Holley HP; Rauch AM
    Antimicrob Agents Chemother; 1996 May; 40(5):1208-13. PubMed ID: 8723468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States.
    Jones RN; Jacobs MR; Washington JA; Pfaller MA
    Diagn Microbiol Infect Dis; 1997 Mar; 27(3):75-83. PubMed ID: 9147008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility of 206 Haemophilus influenzae isolates collected from children in central Italy.
    Zanchi A; Mencarelli M; Sansoni A; Rossolini A; Cellesi C
    Eur J Epidemiol; 1994 Dec; 10(6):699-702. PubMed ID: 7672050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions.
    Hirakata Y; Ohmori K; Mikuriya M; Saika T; Matsuzaki K; Hasegawa M; Hatta M; Yamamoto N; Kunishima H; Yano H; Kitagawa M; Arai K; Kawakami K; Kobayashi I; Jones RN; Kohno S; Yamaguchi K; Kaku M
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4225-30. PubMed ID: 19651910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV
    Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method.
    García-Cobos S; Campos J; Román F; Carrera C; Pérez-Vázquez M; Aracil B; Oteo J
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2407-14. PubMed ID: 18443129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
    McLinn S; Williams D
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of Haemophilus influenzae isolates in Spain to 17 oral antibiotics].
    Aracil B; Gómez-Garcés JL; Alós JI;
    Enferm Infecc Microbiol Clin; 2003 Mar; 21(3):131-6. PubMed ID: 12586017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.
    Torumkuney D; Mayanskiy N; Edelstein M; Sidorenko S; Kozhevin R; Morrissey I
    J Antimicrob Chemother; 2018 Apr; 73(suppl_5):v14-v21. PubMed ID: 29659881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
    Bae S; Lee J; Lee J; Kim E; Lee S; Yu J; Kang Y
    Antimicrob Agents Chemother; 2010 Jan; 54(1):65-71. PubMed ID: 19884366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
    Fuchs PC; Barry AL
    J Clin Microbiol; 1994 Nov; 32(11):2846-50. PubMed ID: 7852584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
    Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG
    CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance among Haemophilus influenzae isolates responsible for lower respiratory tract infections in Poland, 2005-2019.
    Kiedrowska M; Foryś WJ; Gołębiewska A; Waśko I; Ronkiewicz P; Kuch A; Wróbel-Pawelczyk I; Wroczyński M; Hryniewicz W; Skoczyńska A
    Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):961-969. PubMed ID: 35585442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.
    Matic V; Bozdogan B; Jacobs MR; Ubukata K; Appelbaum PC
    J Antimicrob Chemother; 2003 Dec; 52(6):1018-21. PubMed ID: 14585854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.